Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay measures concentrations of the small dense LDL subtype, to better guide clinical care.
(00:32)
Could you both tell us a little about yourselves and your backgrounds?
(01:24)
Could you tell us a little bit about small dense LDL cholesterol and why it is an important marker for helping a physician understand a patient's risk for coronary heart disease?
(03:22)
Could you describe the types of patients who could benefit from having a better understanding of their sdLDL-c levels?
(04:36)
Could you help us understand other tests or methodologies that are currently used to assess cardiovascular risk?
(06:13)
Could you describe Mayo Clinic's new assay for sdLDL-c cholesterol and how it will benefit physicians managing CVD patients?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Closing a Diagnostic Gap for Chronic Diarrhea
Answers from the Lab
Unlock the Full Potential of Research Data
Answers from the Lab
A New Mindset for Leading Through Change
Answers from the Lab
Key Components of Innovation Success
Answers from the Lab